| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,009 |
Intention to continue on-market share buy-back
|
9 Jun 2026 9:04AM |
$20.820 |
$21.280 |
risen by
2.21%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,283 |
Update - Notification of buy-back - WHC
|
9 Jun 2026 9:03AM |
$9.370 |
$7.640 |
fallen by
18.46%
|
|
| Osteopore Limited (OSX) ORDINARY FULLY PAID |
Health Care |
$3 |
Application for quotation of securities - OSX
|
9 Jun 2026 9:03AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
| White Cliff Minerals Limited (WCN) ORDINARY FULLY PAID |
Materials |
$59 |
Trading Halt
|
9 Jun 2026 9:03AM |
$0.015 |
$0.018 |
risen by
20%
|
|
WCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by White Cliff Minerals Limited.
- Pending announcement regarding Rae Copper Project assay results.
- Trading halt in place until 11 June 2026 or announcement release.
- Authorized by the board of White Cliff Minerals Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$592 |
Update - Notification of buy-back - RG1
|
9 Jun 2026 9:02AM |
$2.330 |
$2.520 |
risen by
8.15%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$681 |
Net Tangible Asset Backing
|
9 Jun 2026 9:02AM |
$2.060 |
$2.110 |
risen by
2.43%
|
|
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$123 |
Alterity and FDA Agree on Phase 3 Program for ATH434 in MSA
|
9 Jun 2026 9:01AM |
$0.009 |
$0.565 |
risen by
6,177.78%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Alterity Therapeutics aligns with FDA on Phase 3 program for ATH434.
- Phase 3 trial designed for Multiple System Atrophy (MSA).
- FDA agrees on study design, dosage, and endpoints.
- ATH434 has Fast Track and Orphan Drug Designations.
- Phase 3 trial to initiate by the end of 2026.
- Significant efficacy observed in Phase 2 trials.
- ATH434 shown to reduce a-synuclein pathology.
- Trial aims to support a potential New Drug Application (NDA).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$19 |
Executes New Battery Recycling Framework Agreement with CATL
|
9 Jun 2026 9:00AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Livium Ltd has entered a new Battery Recycling Framework Agreement with CATL HK, a subsidiary of Contemporary Amperex Technology Co., Limited.
- The Agreement formalizes an established working relationship between Envirostream and CATL.
- Envirostream will provide battery collection, logistics, and recycling services.
- The Agreement does not include minimum volume commitments.
- The Agreement has an initial term through May 15, 2029.
- The partnership reinforces Livium's role in the circular battery economy.
- The Agreement supports CATL's regional operations and end-of-life battery management requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eminence Minerals Limited (EMA) ORDINARY FULLY PAID |
Materials |
$8 |
Trading Halt
|
9 Jun 2026 9:00AM |
$0.054 |
$0.040 |
fallen by
25.93%
|
|
EMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested on April 29, 2026.
- Announcement regarding capital raising expected on May 1, 2026.
- Ongoing negative cash flows anticipated due to exploration nature.
- Confidence in securing necessary funding for operations.
- Focus on maintaining operations and fulfilling business objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aurelia Metals Limited (AMI) ORDINARY FULLY PAID |
Materials |
$559 |
Peak Process Plant Upgrade - Tailings Thickener Commissioned
|
9 Jun 2026 9:00AM |
$0.305 |
$0.330 |
risen by
8.20%
|
|
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$441 |
Appointment of Project Director
|
9 Jun 2026 8:59AM |
$0.840 |
$0.805 |
fallen by
4.17%
|
|
| Carnaby Resources Limited (CNB) ORDINARY FULLY PAID |
Materials |
$139 |
Miniboom and Trek 1 Discoveries Update
|
9 Jun 2026 8:59AM |
$0.670 |
$0.505 |
fallen by
24.63%
|
|
CNB - Price-sensitive ASX Announcement
Full Release
Key Points
- Miniboom Lode discovery confirmed with significant drill results.
- Trek 1 discovery shows growth with new high-grade intersections.
- Miniboom located on the edge of Mount Hope Central Ore Reserve open pit.
- Binding Tolling and Offtake agreements signed with Glencore International AG.
- Feasibility Study for Greater Duchess Project expected mid-year 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lakes Blue Energy NL (LKO) ORDINARY FULLY PAID |
Energy |
$34 |
Lakes Advances Wombat-5 Testing
|
9 Jun 2026 8:57AM |
$0.395 |
$0.460 |
risen by
16.46%
|
|
LKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Production testing at Wombat-5 confirms gas-charged reservoir.
- Three gas-bearing zones identified within 1,500 metres.
- Pressure build-up reached 1,800 PSI.
- Plan includes propellant enhanced perforating to improve productivity.
- Next phase of operations targeted for August 2026.
- Wombat 3D seismic reprocessing underway with Geomage Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zenith Minerals Limited (ZNC) ORDINARY FULLY PAID |
Materials |
$63 |
Forrestania and Zenith Minerals Agree Recommended Takeover
|
9 Jun 2026 8:57AM |
$0.090 |
$0.100 |
risen by
11.11%
|
|
ZNC - Price-sensitive ASX Announcement
Full Release
Key Points
- Zenith Minerals Limited has entered into a binding Takeover Implementation Deed with Forrestania Resources Ltd for an off-market scrip takeover.
- Zenith shareholders will receive 1 Forrestania share for every 4.3 Zenith shares held, with an implied offer value of A$0.132 per Zenith share.
- The offer represents a 46.7% premium to Zenith's last closing price.
- Zenith's Board recommends the offer in the absence of a superior proposal.
- The takeover aims to create a larger, more diversified West Australian-focused exploration and development company.
- The transaction includes customary conditions and a minimum acceptance condition of 50.1%.
- Zenith shareholders will maintain exposure to exploration and development opportunities through the combined entity.
- The agreement allows for potential CGT scrip-for-scrip rollover relief for eligible shareholders.
- The combined company will have a portfolio of assets across the Southern Cross, Forrestania, and Eastern Goldfields belts.
- Zenith's Directors, holding approximately 4.5% of Zenith shares, intend to accept the offer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$611 |
Forrestania and Zenith Minerals Agree Recommended Takeover
|
9 Jun 2026 8:57AM |
$0.515 |
$0.385 |
fallen by
25.24%
|
|
FRS - Price-sensitive ASX Announcement
Full Release
Key Points
- Forrestania and Zenith enter into a recommended takeover agreement.
- Zenith shareholders receive 1 Forrestania share for every 4.3 Zenith shares.
- Implied offer value is A$0.132 per Zenith share.
- Transaction aims to create an enlarged West Australian-focused company.
- Minimum acceptance condition of 50.1% required for the transaction.
- Zenith Board recommends shareholders accept the offer.
- Eligible Zenith shareholders may access CGT scrip-for-scrip rollover relief.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| West Cobar Metals Limited (WC1) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
9 Jun 2026 8:52AM |
$0.020 |
$0.014 |
fallen by
30%
|
|
WC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by West Cobar Metals Limited.
- Halt is due to a pending announcement regarding a US project acquisition and capital raising.
- Effective date of halt is immediate, until 11 June 2026 or announcement release.
- Request made under ASX Listing Rule 17.1.
- No known reasons to refuse the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adisyn Ltd (AI1) ORDINARY FULLY PAID |
Information Technology |
$182 |
Repeatable Graphene Deposition Below 300 Degrees Celsius
|
9 Jun 2026 8:51AM |
$0.175 |
$0.155 |
fallen by
11.43%
|
|
AI1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Adisyn Ltd has achieved repeatable graphene deposition below 300°C, verified by UNSW Sydney.
- The process allows continuous graphene film formation on a copper substrate using ALD systems.
- Raman spectroscopy and UHR-TEM imaging confirmed the process consistency and graphene quality.
- Independent verification by UNSW Sydney's Associate Professor Rakesh Joshi.
- Graphene deposition at sub-300°C temperatures is compatible with existing semiconductor fabrication processes.
- Milestone 2 includes successful achievement of reliable, repeatable deposition results.
- Adisyn plans to engage with Tier 1 semiconductor companies for industry adoption.
- The graphene process addresses challenges in semiconductor interconnects, aiming to replace copper due to graphene's superior properties.
- Adisyn holds a US patent for this low-temperature graphene deposition process.
- The company is transitioning from R&D to commercial engagement and scale-up.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nex Metals Exploration Limited (NME) ORDINARY FULLY PAID |
Materials |
$4 |
Kookynie Tailings results confirm Gold, potential Tungsten
|
9 Jun 2026 8:49AM |
$0.018 |
$0.011 |
fallen by
38.89%
|
|
NME - Price-sensitive ASX Announcement
Full Release
Key Points
- Gold grades confirmed at ~1 g/t
- Potential tungsten byproduct identified
- Two 50 kg bulk samples analyzed
- Gravity and cyanidation circuit optimal for recovery
- Representative grades consistent with historical drilling
- Clean environmental profile
- NME's strategy includes Kookynie and WTAC Joint Venture
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$605 |
Update - Notification of buy-back - FPR
|
9 Jun 2026 8:48AM |
$2.800 |
$2.830 |
risen by
1.07%
|
|
| Kuniko Limited (KNI) ORDINARY FULLY PAID |
Materials |
$6 |
Phase 2 Drilling to Commence
|
9 Jun 2026 8:48AM |
$0.033 |
$0.027 |
fallen by
18.18%
|
|
KNI - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 2 diamond drilling to commence in early July 2026.
- Targeting Project MRE Upgrade in H2 2026.
- Drill rig secured with Titeline Drilling for Phase 2.
- Phase 1 drilling exceeded expectations with 100% mineralisation success.
- New mineralised zone discovered at Silica Hill.
- Phase 2 consists of six diamond drill holes, approximately 1,340m.
- Focus on high-grade polymetallic mineralisation at key sites.
- Resource Potentials' targeting review to integrate historical data.
- Expected assay results in September 2026.
- Project MRE upgrade planned for December 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$402 |
Appendix 3Y-Dr Serge Scrofani
|
9 Jun 2026 8:48AM |
$2.700 |
$2.050 |
fallen by
24.07%
|
|
| Southern Cross Gold Consolidated Ltd (SX2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$2,370 |
SX2 Announces Inclusion in the S&P/TSX Composite Index
|
9 Jun 2026 8:47AM |
$10.420 |
$8.800 |
fallen by
15.55%
|
|
| ReadyTech Holdings Limited (RDY) ORDINARY FULLY PAID |
Information Technology |
$198 |
Ceasing to be a substantial holder
|
9 Jun 2026 8:45AM |
$1.610 |
$1.600 |
fallen by
0.62%
|
|
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$32 |
EXERCISE OF QUINN FLUORSPAR OPTION AGREEMENT
|
9 Jun 2026 8:44AM |
$0.125 |
$0.110 |
fallen by
12%
|
|
OD6 - Price-sensitive ASX Announcement
Full Release
Key Points
- OD6 Metals exercises option to acquire Quinn Fluorspar Project in Nevada, USA.
- Confirmed multiple high-grade fluorspar targets across Horseshoe, Mammoth, and Big Jim deposits.
- Historical data indicates potential for Acidspar and Metspar production.
- Recent exploration validated historical data and found new mineralised zones.
- Permitting, metallurgy, and drill planning activities are advancing.
- The project aligns with growing US demand for fluorspar due to its applications in AI semiconductors, batteries, and defence.
- The acquisition requires shareholder approval for issuing shares as consideration.
- OD6 aims to position Quinn Fluorspar as a domestic supply source for the US.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WOTSO (WOT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$86 |
Update - Notification of buy-back - WOT
|
9 Jun 2026 8:43AM |
$0.600 |
$0.530 |
fallen by
11.67%
|
|
Call 1300 880 160
Start a chat
Schedule a call
